Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Genomic Health Inc (GHDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,830,002
  • Shares Outstanding, K 36,123
  • Annual Sales, $ 340,750 K
  • Annual Income, $ -3,860 K
  • 36-Month Beta 0.88
  • Price/Sales 7.67
  • Price/Cash Flow 239.83
  • Price/Book 12.19

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.28
  • Number of Estimates 6
  • High Estimate 0.37
  • Low Estimate 0.19
  • Prior Year 0.13
  • Growth Rate Est. (year over year) +115.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
69.61 +12.56%
on 01/24/19
86.70 -9.63%
on 02/21/19
+5.65 (+7.77%)
since 01/18/19
3-Month
58.47 +33.99%
on 12/24/18
86.70 -9.63%
on 02/21/19
+5.51 (+7.56%)
since 11/21/18
52-Week
30.04 +160.82%
on 04/02/18
92.18 -15.00%
on 11/07/18
+44.87 (+134.02%)
since 02/21/18

Most Recent Stories

More News
Genomic Health I Set to Possibly Rebound After Yesterday's Selloff of 5.79%

Genomic Health I (NASDAQ:GHDX) traded in a range yesterday that spanned from a low of $75.37 to a high of $86.60. Yesterday, the shares fell 5.8%, which took the trading range below the 3-day low of...

GHDX : 78.35 (-6.35%)
Diagnostic Solutions Laboratory Revolutionizes Precision Medicine with GenomicInsight(TM) Genomic Health Profile Powered by Opus23 Explorer(TM)

Diagnostic Solutions Laboratory (DSL) continues its innovative vision to transform and improve personalized medicine by introducing its first DNA SNP test, GenomicInsight(TM) Genomic Health Profile powered...

GHDX : 78.35 (-6.35%)
Genomic Health (GHDX) Beats Q4 Earnings and Revenue Estimates

Genomic Health (GHDX) delivered earnings and revenue surprises of 6.67% and 2.73%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

GHDX : 78.35 (-6.35%)
Genomic Health: 4Q Earnings Snapshot

REDWOOD CITY, Calif. (AP) _ Genomic Health Inc. (GHDX) on Wednesday reported fourth-quarter net income of $8.9 million.

GHDX : 78.35 (-6.35%)
Genomic Health Reports Record 2018 Fourth Quarter and Year-end Financial Results and Provides 2019 Financial Guidance

Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter and year ended December 31, 2018.

GHDX : 78.35 (-6.35%)
Global Liquid Biopsy Market to 2024 Featuring Thermo Fisher Scientific, Roche Diagnostics, Bio-Rad Labs, Biocept, Biocartis, Myriad Genetics, Genomic Health, NeoGenomics Laboratories, & Qiagen

The "Liquid Biopsy Market, Global Analysis by Cancer, Product, Circulating Biomarkers, Clinical Application, Regions, and Companies" report has been added to ResearchAndMarkets.com's offering.

GHDX : 78.35 (-6.35%)
MYGN : 31.70 (-0.88%)
What's in the Cards for Genomic Health (GHDX) in Q4 Earnings?

Genomic Health (GHDX) is expected to gain from higher Oncotype DX breast cancer test revenues in Q4.

WMGI : 31.59 (+0.25%)
CVS : 62.35 (-2.91%)
GHDX : 78.35 (-6.35%)
MASI : 128.81 (+0.02%)
Genomic Health to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call on Wednesday, February 20, 2019

Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Wednesday, February 20 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end...

GHDX : 78.35 (-6.35%)
Oncotype DX® Genomic Prostate Score® Established as First Genomic Test with Prospective Validation for Predicting Adverse Pathology in Newly Diagnosed Patients

Genomic Health, Inc. (Nasdaq: GHDX) today announced the publication of results from a multi-center, prospective validation study of the Oncotype DX® Genomic Prostate Score® (GPS(TM)) test in newly diagnosed...

GHDX : 78.35 (-6.35%)
Is Genomic Health (GHDX) Stock Outpacing Its Medical Peers This Year?

Is (GHDX) Outperforming Other Medical Stocks This Year?

GHDX : 78.35 (-6.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade GHDX with:

Business Summary

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. It launched its first test, Oncotype DX, which has been shown to predict...

See More

Key Turning Points

2nd Resistance Point 92.22
1st Resistance Point 85.28
Last Price 78.35
1st Support Level 72.83
2nd Support Level 67.32

See More

52-Week High 92.18
Last Price 78.35
Fibonacci 61.8% 68.44
Fibonacci 50% 61.11
Fibonacci 38.2% 53.78
52-Week Low 30.04

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar